在心脏骤停患者中非遮蔽性间腔性缺血
Jana Smalcova1,2, Jan Belohlavek2,3
1Anaesthesiology and Resuscitation Department, Cardiac Centre, Institute for Clinical and Experimental Medicine, 14000 Prague, Czech Republic.
Reviews in cardiovascular medicine
|July 30, 2024
概括
非封闭性介质缺血 (NOMI) 是心脏骤停 (CA) 后的一种严重并发症. 早期诊断和理解NOMI
科学领域:
- 关键护理医学 关键护理医学
- 胃肠病学 胃肠病学
- 心脏病学 心脏病学
背景情况:
- 非封闭性介质缺血 (NOMI) 是心脏骤停 (CA) 后的一种严重并发症.
- 诊断NOMI具有挑战性,可用的治疗选择有限.
- 肠细胞对缺血的敏感性突出显示了缺血-再输血损伤在CA后NOMI中的作用.
研究的目的:
- 总结有关心脏骤停患者NOMI病理生理学,诊断,治疗和预后意义的当前知识.
- 强调NOMI的作用不仅仅是并发症,而且是在复苏后护理中的预后标记.
主要方法:
- 在心脏骤停的背景下对非封闭性介质缺血的当前文献的综述.
- 综合有关NOMI的机制,诊断挑战,治疗策略和对患者结果的影响信息.
主要成果:
- NOMI的发病率和严重程度与CA后的缺血和再流损伤的强度和持续时间相关.
- 在经历心脏骤停的患者中,NOMI与不良的神经结果有关.
- 这篇论文巩固了对NOMI在心脏骤停后护理中的复杂作用的理解.
结论:
- 非封闭性介质缺血是心脏骤停幸存者的关键并发症和预后指标.
- 进一步研究NOMI的病理生理学和治疗对于改善心脏骤停后患者的结果至关重要.
相关概念视频
Ischemic Heart Disease: Overview
4.0K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
4.0K
Acute Coronary Syndrome I: Introduction
1.8K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.8K
Acute Coronary Syndrome IV: Interprofessional Care
487
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
487
Angina II: Classification
646
Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
646
Introduction Cardiac Emergencies
525
Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
525
Cardiopulmonary Resuscitation IV: Pharmacological Management
1.4K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.4K


